Biormed S.A.S. Company Profile - Ecuador | Financials & Key Executives

Biormed S.A.S. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers

Secondary Activities: Pharmaceutical and Medicine Manufacturing | Computer and Computer Peripheral Equipment and Software Merchant Wholesalers | Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers | Machinery, Equipment, and Supplies Merchant Wholesalers | Grain and Field Bean Merchant Wholesalers | Miscellaneous Nondurable Goods Merchant Wholesalers | Retail Trade | Health and Personal Care Stores | Pharmacies and Drug Stores | Electronic Shopping and Mail-Order Houses

Full name: Biormed S.A.S.

Profile Updated: April 10, 2023

Biormed S.A.S. is an enterprise located in Ecuador, with the main office in Quito. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on August 03, 2020. Its total assets decreased by 20.5% over the same period.

Headquarters
Gaspar de Villaroel S1-58, Plaza 6 Bldg. , Floor 59
Quito; Pichincha;

Contact Details: Purchase the Biormed S.A.S. report to view the information.

Basic Information

Outstanding Shares:

Purchase the Biormed S.A.S. report to view the information.

Registered Capital:

Purchase the Biormed S.A.S. report to view the information.

Incorporation Date:

August 03, 2020

Key Executives

Purchase this report to view the information.

President

Purchase this report to view the information.

General Manager

Ownership Details

Purchase this report to view the information.

50%

Purchase this report to view the information.

50%

Company Performance

Financial values in the chart are available after Biormed S.A.S. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.

Operating profit (EBIT)

N/A

EBITDA

N/A

Net Profit (Loss) for the Period

N/A

Total assets

-20.5%▼

Total equity

-28.21%▼

Return on Equity (ROE)

N/A

Quick Ratio

-0.31%▼

Cash Ratio

-0.02%▼